Takeda Pharmaceutical Company Limited | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (21)

Latest Posts

About This Stock More About This Stock
More Than 140 Drug Brands Will Have Their Prices Hiked Heading Into 2024
Article By: Tyler Durden
Thursday, January 4, 2024 1:10 AM EST
More than 140 brands of drugs are going to see their prices hiked heading into the new year
In this article: GSK, PFE, SNY, TAK
Read
Week In Review: China's Biopharmas Announce $2.5 Billion In Deals
Article By: ChinaBio® Today
Saturday, October 21, 2023 1:39 PM EST
KBP Biosciences sold global rights for its hypertension candidate to Novo Nordisk in an agreement worth up to $1.3 billion. Also, EpimAb Bio sold the rights to use its Fabs-In-Tandem Immunoglobulin platform to Almirall in a $210 million agreement.
In this article: SRXXF, BGNE, WXXWY, ASPHF, NVO, LBTSF, TAK
Read
Week In Review: Billion Dollar Deals - Moderna’s Shanghai Investment And F-Star’s Takeda Collaboration
Article By: ChinaBio® Today
Saturday, July 8, 2023 2:18 PM EST
F-star Therapeutics formed a license agreement with Takeda to develop Fcab domains aimed at undisclosed immuno-oncology targets. Also, Brii Bio signed a global license to an HBV immunotherapeutic therapy developed by VBI Vaccines for $15 million.
In this article: TAK, BRIBF Also: MRNA, ARGX, VBIV, ZLAB, IVBXF
Read
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
Article By: ChinaBio® Today
Saturday, January 28, 2023 3:00 PM EST
Shanghai’s HutchMed out-licensed global rights for a colorectal cancer therapy to Japan’s Takeda in a deal worth up to $1.13 billion, including $400 million upfront. In addition to the $1.13 billion, HutchMed will also pay royalties on net sales.
In this article: HCM, TAK Also: SMMT, LEGN, SBHMY, SHJBF, ASCLF
Read
Stock Analysis: Takeda Pharmaceutical
Article By: Fredrik Arnold
Monday, January 23, 2023 9:17 PM EST
In the past year, Takeda’s share price increased by $1.73, or about 12%.
In this article: TAK
Read

Latest Tweets for $TAK

No tweets yet!

PARTNER HEADLINES